Site Number - 1012 — Chicago, Illinois

Site Number - 1012 is a clinical research site located in Chicago, Illinois, United States 60607.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site Number - 1012 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Primary Sjögren's Syndrome.

Sponsors: Immunovant Sciences GmbH.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Number - 1012?

Site Number - 1012 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Number - 1012 conducted?

Site Number - 1012 has 1 clinical trials on record, with 1 currently active. Their work covers Primary Sjögren's Syndrome.

Is Site Number - 1012 accredited by Crixeo Health?

Site Number - 1012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Number - 1012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.